Gastric sleeve removes 75–80% of the stomach, creating a tube-shaped pouch. Gastric bypass creates a small stomach pouch AND re-routes the small intestine, causing both restriction and malabsorption. Bypass typically achieves 10% more weight loss and higher Type 2 diabetes remission, but carries higher complication risk and is irreversible. Both are performed abroad for $4,000–$9,000 versus $15,000–$35,000 in the US.
Medically reviewed by Dr. Murat Ustun, M.D., Founder & Medical Director, Flytocure Healthcare.
| Criterion | Option A | Option B |
|---|---|---|
| Mechanism | Restriction only (stomach reduced 75–80%) | Restriction + malabsorption (stomach + intestinal re-route) |
| Average excess weight loss (2 yr) | 60–70% EWL | 70–80% EWL |
| Total body weight loss (2 yr) | 25–35% TBWL | 30–40% TBWL |
| Type 2 diabetes remission | 50–60% remission rate | 70–80% remission rate |
| Hospital stay | 2–3 nights | 3–5 nights |
| Operative time | 60–90 minutes | 90–150 minutes |
| Complication rate (accredited centres) | 0.5–1% | 1.5–3% |
| GERD / acid reflux | May worsen — 15–20% develop new GERD | Resolves GERD in 85–90% of cases |
| Nutritional deficiency risk | Moderate — vitamin D, B12, iron | High — iron, B12, calcium, zinc require lifelong monitoring |
| Reversibility | Permanent — not reversible | Technically reversible but rarely performed |
| Cost abroad (all-inclusive) | $4,000–$6,500 (Turkey/Mexico) | $5,500–$9,000 (Turkey/India) |
| Cost in the US | $15,000–$25,000 | $20,000–$35,000 |
| Minimum BMI | ≥35 (or ≥30 with comorbidities) | ≥35 (or ≥30 with Type 2 diabetes) |
| Best for GERD patients | No — may worsen GERD | Yes — resolves GERD |
| Outcome Metric | Gastric Sleeve (VSG) | Gastric Bypass (RYGB) |
|---|---|---|
| Excess weight loss at 1 year | 55–65% | 65–75% |
| Excess weight loss at 2 years | 60–70% | 70–80% |
| Excess weight loss at 5 years | 50–60% (some regain common) | 55–65% (sustained by malabsorption) |
| Type 2 diabetes remission at 2 yr | 50–60% | 70–80% |
| Hypertension resolution | 60–70% | 70–80% |
| Sleep apnoea resolution | 70–85% | 80–90% |
| Major complication rate | 0.5–1% | 1.5–3% |
| 30-day mortality (accredited centres) | <0.1% | <0.2% |
Gastric bypass (RYGB) achieves 10–15% more excess weight loss on average at 5 years (55–65% EWL for sleeve vs 55–65% for bypass at 5 years, though initial bypass advantage narrows over time). At 10+ years, outcomes are more similar as sleeve patients learn portion control and bypass patients experience some malabsorption adaptation.
Gastric bypass achieves significantly higher Type 2 diabetes remission: 70–80% vs 50–60% for gastric sleeve at 2 years. For patients whose primary goal is diabetes remission (especially insulin-dependent Type 2 diabetics), bypass is the superior choice. Mini-bypass (OAGB) achieves similar remission rates to full bypass with lower complication risk.
Yes. Sleeve-to-bypass revision is one of the most common bariatric revisions. It's performed when sleeve patients experience insufficient weight loss, weight regain after sleeve, or develop severe GERD. Revision surgery is more complex and carries higher risk than primary procedures.
Gastric sleeve costs $4,000–$6,500 in Turkey and $4,500–$7,000 in Mexico. Gastric bypass costs $5,500–$9,000 in Turkey and $5,000–$8,000 in India. Both are 65–80% less expensive than US pricing ($15,000–$35,000).
Not sure which option is right for you? Our AI coordinator Maya can help — or request a free consultation with a qualified surgeon within 24 hours.
Browse 507 Accredited Clinics | Free Cost Calculator | Patient Guide